Frequency of thiopurine S-methyltransferase (TPMT) alleles in Southeast Iranian population

Nucleosides, Nucleotides and Nucleic Acids

Volumn 29, Issue 3, 2010, Pages 237-244

  Bahari, Ali ^a   Hashemi, Mohammad ^a,b   Bari, Zohreh ^a   Moazeni Roodi, Abdolkarim ^c   Kaykhaei, Mahmoud Ali ^a   Narouie, Behzad ^d  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic polymorphism; Iranian; Polymorphism; Thiopurine S methyltransferase

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; DRUG METABOLISM; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION;

ADULT; ALLELES; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; IRAN; MALE; METHYLTRANSFERASES; POLYMORPHISM, GENETIC;

EID: 77951443953     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257771003720418     Document Type: Article

References (41)

1. Coulthard, S.; Hogarth, L. The thiopurines: an update. Invest. New Drugs, 2005, 23(6), 523-532.
2. Sahasranaman, S.; Howard, D.; Roy, S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur. J. Clin. Pharmacol. 2008, 64(8), 753-767.
3. Xin, H.W.; Xiong, H.; Wu, X.C.; Li, Q.; Xiong, L.; Yu, A.R. Relationships between thiopurine Smethyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients. Eur. J. Clin. Pharmacol. 2009, 65(3), 249-255.
4. Tai, H.L.; Krynetski, E.Y.; Yates, C.R.; Loennechen, T.; Fessing, M.Y.; Krynetskaia, N.F.; Evans, W.E. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am. J. Hum. Genet. 1996, 58(4), 694-702.
5. Yates, C.R.; Krynetski, E.Y.; Loennechen, T.; Fessing, M.Y.; Tai, H.L.; Pui, C.H.; Relling, M.V.; Evans, W.E. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 1997, 126(8), 608-614.
6. Otterness, D.; Szumlanski, C.; Lennard, L.; Klemetsdal, B.; Aarbakke, J.; Park-Hah, J.O.; Iven, H.; Schmiegelow, K.; Branum, E.; O'Brien, J.; et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin. Pharmacol. Ther. 1997, 62(1), 60-73.
7. Lennard, L.; Gibson, B.E.; Nicole, T.; Lilleyman, J.S. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch. Dis. Child. 1993, 69(5), 577-579.
8. Lennard, L.; Van Loon, J.A.; Weinshilboum, R.M. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin. Pharmacol. Ther. 1989, 46(2), 149-154.
9. Gardiner, S.J.; Gearry, R.B.; Begg, E.J.; Zhang, M.; Barclay, M.L. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold. Clin. Gastroenterol. Hepatol. 2008, 6(6), 654-660; quiz 604.
10. Tassaneeyakul, W.; Srimarthpirom, S.; Reungjui, S.; Chansung, K.; Romphruk, A. Azathioprineinduced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*233A1/*233A3C3C. Transplantation 2003, 76(1), 265-266.
11. Slanar, O.; Chalupna, P.; Novotny, A.; Bortlik, M.; Krska, Z.; Lukas, M. Fatal myelotoxicity after azathioprine treatment. Nucleosides Nucleotides Nucleic Acids 2008, 27(6), 661-665.
12. Relling, M.V.; Hancock, M.L.; Rivera, G.K.; Sandlund, J.T.; Ribeiro, R.C.; Krynetski, E.Y.; Pui, C.H.; Evans, W.E. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine Smethyltransferase gene locus. J. Natl. Cancer Inst. 1999, 91(23), 2001-2008.
13. Evans, W.E.; Hon, Y.Y.; Bomgaars, L.; Coutre, S.; Holdsworth, M.; Janco, R.; Kalwinsky, D.; Keller, F.; Khatib, Z.; Margolin, J.; et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J. Clin. Oncol. 2001, 19(8), 2293-2301.
14. Black, A.J.; McLeod, H.L.; Capell, H.A.; Powrie, R.H.; Matowe, L.K.; Pritchard, S.C.; Collie-Duguid, E.S.; Reid, D.M. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann. Intern. Med. 1998, 129(9), 716-718.
15. Krynetski, E.Y.; Evans, W.E. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance. Pharmacology 2000, 61(3), 136-146.
16. Wang, L.; Weinshilboum, R. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Oncogene 2006, 25(11), 1629-1638.
17. Hashemi, M.; Moazeni-Roodi, K.; Fazaeli, A.; Sandoughi, M.; Bardestani, G.; Kordi-Tamandani, D.M.; Ghavami, S. Lack of association between paraoxonasae-1 Q192R polymorphism and rheumatoid arthritis in Southeast Iran. Gent. Mol. Res. 2010, 9(1), 333-339.
18. Roberts, R.L.; Barclay, M.L.; Gearry, R.B.; Kennedy, M.A. A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations. Clin. Chim. Acta 2004, 341(1-2), 49-53.
19. Weinshilboum, R.M.; Sladek, S.L. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am. J. Hum. Genet. 1980, 32(5), 651-662.
20. Fargher, E.A.; Tricker, K.; Newman, W.; Elliott, R.; Roberts, S.A.; Shaffer, J.L.; Bruce, I.; Payne, K. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J. Clin. Pharm. Ther. 2007, 32(2), 187-195.
21. Rutherford, K.; Daggett, V. Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics. J. Mol. Biol. 2008, 379(4), 803-814.
22. Lindqvist, M.; Skoglund, K.; Karlgren, A.; Soderkvist, P.; Peterson, C.; Kidhall, I.; Almer, S. Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*233A3A and identification of a novel sequence variant, TPMT*2323. Pharmacogenet. Genomics 2007, 17(10), 891-895.
23. Schaeffeler, E.; Eichelbaum, M.; Reinisch, W.; Zanger, U.M.; Schwab, M. Three novel thiopurine Smethyltransferase allelic variants (TPMT*20, *21, *22)-association with decreased enzyme function. Hum. Mutat. 2006, 27(9), 976.
24. Chang, J.G.; Lee, L.S.; Chen, C.M.; Shih, M.C.; Wu, M.C.; Tsai, F.J.; Liang, D.C. Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics 2002, 12(3), 191-195.
25. Hiratsuka, M.; Inoue, T.; Omori, F.; Agatsuma, Y.; Mizugaki, M. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat. Res. 2000, 448(1), 91-95.
26. Kham, S.K.; Tan, P.L.; Tay, A.H.; Heng, C.K.; Yeoh, A.E.; Quah, T.C. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 2002, 24(5), 353-359.
27. Collie-Duguid, E.S.; Pritchard, S.C.; Powrie, R.H.; Sludden, J.; Collier, D.A.; Li, T.; McLeod, H.L. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999, 9(1), 37-42.
28. Lee, S.S.; Kim, W.Y.; Jang, Y.J.; Shin, J.G. Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations. Clin. Chim. Acta 2008, 398(1-2), 82-85.
29. Kubota, T.; Chiba, K. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus. Br. J. Clin. Pharmacol. 2001, 51(5), 475-477.
30. Hon, Y.Y.; Fessing, M.Y.; Pui, C.H.; Relling, M.V.; Krynetski, E.Y.; Evans, W.E. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum. Mol. Genet. 1999, 8(2), 371-376.
31. Schaeffeler, E.; Fischer, C.; Brockmeier, D.; Wernet, D.; Moerike, K.; Eichelbaum, M.; Zanger, U.M.; Schwab, M. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004, 14(7), 407-417.
32. Kurzawski, M.; Gawronska-Szklarz, B.; Drozdzik, M. Frequency distribution of thiopurine Smethyltransferase alleles in a polish population. Ther. Drug. Monit. 2004, 26(5), 541-545.
33. Rossino, R.; Vincis, C.; Alves, S.; Prata, M.J.; Macis, M.D.; Nucaro, A.L.; Schirru, E.; Congia, M. Frequency of the thiopurine S-methyltransferase alleles in the ancient genetic population isolate of Sardinia. J. Clin. Pharm. Ther. 2006, 31(3), 283-287.
34. Taja-Chayeb, L.; Vidal-Millan, S.; Gutierrez, O.; Ostrosky-Wegman, P.; Duenas-Gonzalez, A.; Candelaria, M. Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients. Med. Oncol. 2008, 25(1), 56-62.
35. Boson, W.L.; Romano-Silva, M.A.; Correa, H.; Falcao, R.P.; Teixeira-Vidigal, P.V.; De Marco, L. Thiopurine methyltransferase polymorphisms in a Brazilian population. Pharmacogenomics J. 2003, 3(3), 178-182.
36. Haglund, S.; Lindqvist, M.; Almer, S.; Peterson, C.; Taipalensuu, J. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin. Chem. 2004, 50(2), 288-295.
37. Azad, M.; Kaviani, S.; Soleimani, M.; Noruzinia, M.; Hajfathali, A. Common Polymorphism's Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population. Yakhteh 2009, 11(3), 311-316.
38. Zhang, J.P.; Guan, Y.Y.; Wu, J.H.; Jiang, W.Q.; Huang, M. [Genetic polymorphism of the thiopurine S-methyltransferase of healthy Han Chinese]. Ai Zheng 2003, 22(4), 385-388.
39. Milek, M.; Murn, J.; Jaksic, Z.; Lukac Bajalo, J.; Jazbec, J.; Mlinaric Rascan, I. Thiopurine Smethyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population. Pharmacology 2006, 77(3), 105-114.
40. Slanar, O.; Bortlik, M.; Buzkova, H.; Donoval, R.; Pechandova, K.; Sebesta, I.; Lukas, M.; Perlik, F. Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease. Nucleosides Nucleotides Nucleic Acids 2008, 27(6), 835-838.
41. Hamdy, S.I.;Hiratsuka, M.; Narahara, K.; Endo, N.; El-Enany, M.; Moursi, N.; Ahmed, M.S.; Mizugaki, M. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br. J. Clin. Pharmacol. 2003, 55(6), 560-569.